LP
LIGAND PHARMACEUTICALS
LGND· Health Care· BiotechnologyS&P 600
Close · 26/10/2026
308.30
1D
+1.57%52-week range
175.89 – 326.63
Volume
1,94,800.00
Price history
LGND
25/09/2026 to 26/10/2026
O 304.39 H 309.43 L 303.47
1W+3.71%
1M+2.25%
3M+4.06%
6M+27.51%
1Y+66.42%
3Y+484.12%
5Y+284.39%
MAX+325.53%
Fundamentals
as of 26/10/2026- Market cap
- $6.15B
- Shares out
- 19.94M
- P/E (trailing)
- 31.16
- P/E (forward)
- 25.38
- EPS (trailing)
- 9.89
- Dividend yield
- 0.00%
- Beta
- 1.01
- Profit margin
- 67.88%
- P/B
- 6.35
- Return on equity
- 20.38%
SEC financial statements
61 quarterly and 17 annual periods through 30/06/2026.
Details
- Ticker
- LGND
- Index
- SP600
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 26/10/2026.
Tracked by Congress
1 filer · 0 on watchlist · 4 buys · 0 sells · D: 4
- 29/05/2026Gilbert CisnerosBuyLigand Pharmaceuticals Incorporated - Common Stock$1,001–$15,000
- 03/03/2026Gilbert CisnerosBuyLigand Pharmaceuticals Incorporated - Common Stock$1,001–$15,000
- 15/01/2026Gilbert CisnerosBuyLigand Pharmaceuticals Incorporated - Common Stock$1,001–$15,000
- 05/01/2026Gilbert CisnerosBuyLigand Pharmaceuticals Incorporated - Common Stock$1,001–$15,000